Rapidly destructive Staphylococcus epidermidis endocarditis
Related Experiment Video
Updated: Aug 17, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
A S Zinkernagel1, R F Speck, C Ruef
1Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, Raemistr. 100, 8091 Zurich, Switzerland. annelies.zinkernagel@usz.ch
Abstract:
A 29-year-old man with rapidly destructive Staphylococcus epidermidis endocarditis after mitral valve reconstruction is presented. Resistance to rifampin and teicoplanin occurred during antibiotic treatment resulting in clinical failure and valve destruction. Subsequently, the patient was successfully treated, by combining valve replacement with antibiotic therapy including quinupristin/dalfopristin, levofloxacin, and vancomycin. In conclusion, S. epidermidis can cause rapid valve destruction with large vegetations, and combination of surgery and antibiotic therapy may be necessary.
Related Concept Videos
Staphylococcal Skin Infections
Rheumatic Heart Disease I: Introduction
Clinical Significance of Antibiotic Resistance
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction